Cargando…

Randomised, double-blind, placebo-controlled trial of glycopyrronium in children and adolescents with severe sialorrhoea and neurodisabilities: protocol of the SALIVA trial

INTRODUCTION: Severe sialorrhoea is a common, distressing problem in children/adolescents with neurodisabilities, which has adverse health and social consequences. The SALIVA trial is designed to evaluate the efficacy and safety of a paediatric-specific oral solution of glycopyrronium along with its...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fayoux, Pierre, Dinomais, Mickael, Shaw, Helen, Probert, Nick, Villain, Frédéric, Pouchain, Denis, Texier, Nathalie, Auvin, Stéphane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173983/ https://www.ncbi.nlm.nih.gov/pubmed/37156563 http://dx.doi.org/10.1136/bmjpo-2023-001913

Ejemplares similares

The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability
por: Parr, Jeremy R, et al.
Publicado: (2014)

Sialorrhoea and Ptyalomania
Publicado: (1914)

Drooling Reduction Intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability
por: Parr, Jeremy R, et al.
Publicado: (2018)

An unusual complication of Botox treatment for sialorrhoea
por: Layton, Thomas Benjamin
Publicado: (2014)

Review of Psychotropic Agents Associated with Sialorrhoea, Except Clozapine
por: Halder, Ankit, et al.
Publicado: (2021)

The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin®)
por: Morgante, Francesca, et al.
Publicado: (2019)

Effect of indacaterol/glycopyrronium on ventilation and perfusion in COPD: a randomized trial
por: Singh, Dave, et al.
Publicado: (2022)

Exploratory study of the effectiveness of nebulised saline in children with neurodisability
por: Galaz Souza, Natalia, et al.
Publicado: (2021)

Parenteral Nutrition in Pediatric Patients with Neurodisability: Current Perspectives
por: White, Emily, et al.
Publicado: (2023)

Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated
por: Restivo, Domenico A., et al.
Publicado: (2018)

Perspectives on “Disease” and “Disability” in Child Health: The Case of Childhood Neurodisability
por: Miller, Anton Rodney, et al.
Publicado: (2016)

Paediatric neurodisability and sleep disorders: clinical pathways and management strategies
por: McDonald, Aoife, et al.
Publicado: (2019)

An evaluation of predictors for success of two-duct ligation for drooling in neurodisabilities
por: Bekkers, Stijn, et al.
Publicado: (2020)

Repeated onabotulinum neurotoxin A injections for drooling in children with neurodisability
por: Bekkers, Stijn, et al.
Publicado: (2021)

Evaluating a community respiratory physiotherapy service for children with neurodisability
por: Smith, Samantha, et al.
Publicado: (2022)

Sarcopenic Obesity in Individuals With Neurodisabilities: The SarcObeNDS Study
por: Dionyssiotis, Yannis, et al.
Publicado: (2022)

“It means you are grounded” – caregivers’ perspectives on the rehabilitation of children with neurodisability in Malawi
por: Paget, Amelia, et al.
Publicado: (2016)

Neurodisability with Severe Restriction of Mobility Is Associated with Reduced Serum Creatinine Values
por: Lim, Chun, et al.
Publicado: (2019)

Neurodisability among Children at the Nexus of the Child Welfare and Youth Justice System
por: Baidawi, Susan, et al.
Publicado: (2020)

Pseudomonas aeruginosa infection in respiratory samples in children with neurodisability—to treat or not to treat?
por: Gregson, Elizabeth, et al.
Publicado: (2021)

O014 Tolerance of polysomnography in children with neurodisability versus neurotypical peers
por: Lanzlinger, D, et al.
Publicado: (2022)

COPD and glycopyrronium responsiveness assessment: An appraisal
por: Bhattacharyya, Parthasarathi, et al.
Publicado: (2023)

Indacaterol/glycopyrronium versus tiotropium or glycopyrronium in long‐acting bronchodilator‐naïve COPD patients: A pooled analysis
por: Muro, Shigeo, et al.
Publicado: (2019)

Development and evaluation of a community respiratory physiotherapy service for children with severe neurodisability
por: Wolff, Antonia, et al.
Publicado: (2015)

Development of a reliable clinical assessment tool for meningoencephalitis in dogs: The neurodisability scale
por: Gonçalves, Rita, et al.
Publicado: (2023)

Artificial Saliva in Diabetic Xerostomia (ASDIX): Double Blind Trial of Aldiamed(®) Versus Placebo
por: Sinjari, Bruna, et al.
Publicado: (2020)

Comparative efficacy and safety of glycopyrronium/formoterol fixed-dose combination versus glycopyrronium monotherapy in patients with moderate-to–severe COPD
por: Salvi, Sundeep, et al.
Publicado: (2022)

Budesonide/Glycopyrronium/Formoterol: A Review in COPD
por: Heo, Young-A
Publicado: (2021)

Randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of three doses of co-suspension delivery technology glycopyrronium MDI in Japanese patients with moderate-to-severe COPD
por: Fukushima, Yasushi, et al.
Publicado: (2018)

Terminology and descriptions of navigation and related practices for children with neurodisability and their families: a scoping review
por: Gardiner, Emily, et al.
Publicado: (2022)

Efficacy and safety of direct switch to indacaterol/glycopyrronium in patients with moderate COPD: the CRYSTAL open-label randomised trial
por: Vogelmeier, Claus F., et al.
Publicado: (2017)

Efficacy of indacaterol/glycopyrronium versus salmeterol/fluticasone in current and ex-smokers: a pooled analysis of IGNITE trials
por: Halpin, David M.G., et al.
Publicado: (2021)

Relieving exertional dyspnea during the 3-min constant speed shuttle test in patients with COPD with indacaterol/glycopyrronium versus tiotropium: the RED trial
por: Beaulieu, Jessie, et al.
Publicado: (2020)

Key health outcomes for children and young people with neurodisability: qualitative research with young people and parents
por: Allard, Amanda, et al.
Publicado: (2014)

Meaningful health outcomes for paediatric neurodisability: Stakeholder prioritisation and appropriateness of patient reported outcome measures
por: Morris, Christopher, et al.
Publicado: (2015)

Protocol for a scoping review about ethics in transition programmes for adolescents and young adults with neurodisabilities
por: Bogossian, Aline, et al.
Publicado: (2018)

Oral melatonin for non‐respiratory sleep disturbance in children with neurodisabilities: systematic review and meta‐analyses
por: Parker, Adwoa, et al.
Publicado: (2019)

Trajectories of poverty and economic hardship among American families supporting a child with a neurodisability
por: Rothwell, D. W., et al.
Publicado: (2019)

Unmet healthcare needs in adults with childhood-onset neurodisabilities: a protocol for a systematic review
por: Meehan, Elaine, et al.
Publicado: (2021)

Identification of the needs of children with neurodisability and their families at different stages of development: A qualitative study protocol
por: Roldán-Pérez, Patricia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7rcbc8jsvu1knkhrd526mfl98h